These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 3105568)
1. Comparative haemodynamic effects of intravenous lignocaine, disopyramide and flecainide in uncomplicated acute myocardial infarction. Silke B; Frais MA; Verma SP; Reynolds GW; Hafizullah M; Kalra PA; Jackson NC; Taylor SH Br J Clin Pharmacol; 1986 Dec; 22(6):707-14. PubMed ID: 3105568 [TBL] [Abstract][Full Text] [Related]
2. Hemodynamic dose-response effects of flecainide in acute myocardial infarction with and without left ventricular decompensation. Jackson N; Verma SP; Frais MA; Silke B; Hafizullah M; Reynolds G; Taylor SH Clin Pharmacol Ther; 1985 Jun; 37(6):619-24. PubMed ID: 3891187 [TBL] [Abstract][Full Text] [Related]
3. Intravenous disopyramide in myocardial infarction: a haemodynamic study. Marrott PK; Nairn PL; Hill PD; Turner G; Sharman J N Z Med J; 1983 Jan; 96(723):4-7. PubMed ID: 6571755 [TBL] [Abstract][Full Text] [Related]
4. Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction. Silke B; Frais MA; Verma SP; Reynolds G; Taylor SH Eur J Clin Pharmacol; 1986; 29(6):659-65. PubMed ID: 2872054 [TBL] [Abstract][Full Text] [Related]
5. Comparative haemodynamic dose-response effects of dobutamine and amrinone in left ventricular failure complicating acute myocardial infarction. Silke B; Verma SP; Midtbo KA; Reynolds G; Taylor SH J Cardiovasc Pharmacol; 1987 Jan; 9(1):19-25. PubMed ID: 2434789 [TBL] [Abstract][Full Text] [Related]
6. [Effect of class I anti-arrhythmia agents on the signal-averaged ECG]. Goedel-Meinen L; Hofmann M; Schmidt G; Barthel P; Baedeker W; Blömer H Herz; 1988 Jun; 13(3):188-96. PubMed ID: 3136064 [TBL] [Abstract][Full Text] [Related]
7. Intravenous disopyramide in acute myocardial infarction: a haemodynamic and pharmacokinetic study. Cameron J; Stafford W; Pritchard D; Norris R; Ravenscroft P J Cardiovasc Pharmacol; 1984; 6(1):126-31. PubMed ID: 6199595 [TBL] [Abstract][Full Text] [Related]
8. Haemodynamic effects of disopyramide using a new model of intravenous administration. Bonde J; Pedersen LE; Angelo HR; Svendsen TL; Trap-Jensen J; Graudal NA; Kampmann JP Pharmacol Toxicol; 1987 Mar; 60(3):179-83. PubMed ID: 3588512 [TBL] [Abstract][Full Text] [Related]
9. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction. Rønnevik PK; Gundersen T; Abrahamsen AM Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718 [TBL] [Abstract][Full Text] [Related]
10. Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy. Kimball BP; Bui S; Wigle ED Am Heart J; 1993 Jun; 125(6):1691-7. PubMed ID: 8498312 [TBL] [Abstract][Full Text] [Related]
11. Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide. Allen-Narker RA; Roberts CJ; Marshall AJ; Jordan SC; Barritt DW; Goodfellow RM Br J Clin Pharmacol; 1984 Nov; 18(5):725-32. PubMed ID: 6439233 [TBL] [Abstract][Full Text] [Related]
12. Haemodynamic and electrocardiographic effects of intravenous disopyramide (rythmodan) following acute myocardial infarction. Davies GJ; Marrott PK; Muir JR Br J Clin Pharmacol; 1979 Feb; 7(2):183-7. PubMed ID: 760751 [TBL] [Abstract][Full Text] [Related]
13. Studies on the preventive method of lowered ventricular fibrillation threshold during experimental acute myocardial infarctions. A comparison between disopyramide phosphate and lidocaine. Hori Y; Okamoto R; Hatani M; Imai N; Toh H; Takano S; Nadai T; Fukuzaki H Jpn Heart J; 1981 Sep; 22(5):801-13. PubMed ID: 7321204 [TBL] [Abstract][Full Text] [Related]
14. Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction. Leach AJ; Brown JE; Armstrong PW Am J Med; 1980 Jun; 68(6):839-44. PubMed ID: 7386491 [TBL] [Abstract][Full Text] [Related]
15. Effects of intravenous disopyramide on coronary hemodynamics and vasodilator reserve in hypertrophic obstructive cardiomyopathy. Hongo M; Nakatsuka T; Takenaka H; Tanaka M; Watanabe N; Yazaki Y; Sekiguchi M Cardiology; 1996; 87(1):6-11. PubMed ID: 8631046 [TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled study to determine the efficacy of oral disopyramide phosphate for the prophylaxis of ventricular dysrhythmias after acute myocardial infarction. Kumana CR; Rambihar VS; Tanser PH; Cairns JA; Gupta RN; Wildeman RA; Johnston M; Johnson AL; Gent M Br J Clin Pharmacol; 1982 Oct; 14(4):519-27. PubMed ID: 6753887 [TBL] [Abstract][Full Text] [Related]
17. Haemodynamic dose-response effects of i.v. nicardipine in coronary artery disease. Silke B; Verma SP; Nelson GI; Hussain M; Taylor SH Br J Clin Pharmacol; 1984 Nov; 18(5):717-24. PubMed ID: 6508981 [TBL] [Abstract][Full Text] [Related]
18. Acute haemodynamic effects of the antiarrhythmic agent pirmenol in cardiac patients: a comparison with lidocaine. Nieminen MS; Toivonen LK; Manninen V; Frick MH Eur Heart J; 1986 Feb; 7(2):150-7. PubMed ID: 3516703 [TBL] [Abstract][Full Text] [Related]
19. Haemodynamic dose-response effects of intravenous indoramin in acute heart failure complicating myocardial infarction. Silke B; Nelson GI; Verma SP; Frais MA; Reynolds G; Jackson N; Taylor SH J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S102-6. PubMed ID: 2423781 [TBL] [Abstract][Full Text] [Related]
20. Flecainide compared with a combination of digoxin and disopyramide for acute atrial arrhythmias after cardiopulmonary bypass. Gavaghan TP; Koegh AM; Kelly RP; Campbell TJ; Thorburn C; Morgan JJ Br Heart J; 1988 Dec; 60(6):497-501. PubMed ID: 3146989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]